$NIKA News
Last published 2mo ago
- 2mo agoNIKANika Pharmaceuticals, Inc. (OTCQB: NIKA) Funding UpdateGlobeNewswireHENDERSON, Nev., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA) is continuing its ongoing negotiation with investors from Thailand, Japan, Switzerland, Luxembourg, USA, Bulgaria, and the
- 11mo agoNIKANika Pharmaceuticals, Inc. (NIKA) Progress UpdateGlobeNewswireHENDERSON, Nev., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA) appeared on The Street Reports podcast where CEO Dimitar Savov shared the progress the company has made thus far and outlined
- 1y agoADIAATNMBPTHCNVIF+12Life Sciences Investor Forum: Now Available for Online ViewingGlobeNewswireNEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Investor Forum, held June 11th and
- 1y agoNIKAUPDATE - Nika Pharmaceuticals, Inc. to Present at the Life Sciences Virtual Investor Forum June 11th-12thGlobeNewswireHENDERSON, Nev., June 12, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB:NIKA), based in Colorado, focused on cures for life-threatening diseases, today announced that Dimitar Savov, CEO, will present live
- 1y agoADIAATNMBPTHCNVIF+12Life Sciences Investor Forum Agenda Announced for June 11th-12thGlobeNewswireNEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Life Sciences Investor Forum June 11th & 12th. This event is
- 1y agoNIKANika Pharmaceuticals, Inc. to Present at the Life Sciences Virtual Investor Forum June 11th-12thGlobeNewswireHENDERSON, Nev., June 10, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB:NIKA), based in Colorado, focused on cures for life-threatening diseases, today announced that Dimitar Savov, CEO, will present live
- 1y agoNIKANika Pharmaceuticals, Inc. (NIKA) Markets Analysis and €8.5 Billion Projected RevenueGlobeNewswireHENDERSON, Nev., May 19, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA) presents projected revenue for each market with exclusive distribution agreement. NIKA has previously reported an estimated
- 1y agoNIKANika Pharmaceuticals, Inc. (NIKA) Latest DevelopmentsGlobeNewswireHENDERSON, Nev., April 11, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA) published a report on the therapeutic effect and potential economic impact of ITV-1. The document contains the company's
- 2y agoNIKANika Pharmaceuticals, Inc. (NIKA) Signed a Distribution Agreement for NigeriaGlobeNewswireHENDERSON, Nev., July 18, 2024 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCMKTS: NIKA) announces the signing of a distribution agreement for the Republic of Nigeria. The extensive negotiations with
- 2y agoNIKANika Pharmaceuticals, Inc. (NIKA) Presents Its Business StrategyGlobeNewswireHENDERSON, Nev., June 03, 2024 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCMKTS: NIKA) introduces its plans to develop the company into a sustainable business project that will consistently grow, bring good